Przeszkody i ułatwienia w leczeniu lęku i depresji u pacjentów z epilepsją: badanie jakościowe na podstawie doświadczeń pacjentów
Barriers and facilitators to anxiety and depression treatment in epilepsy: A qualitative interview study of patient perspectives
W skrócie
Badanie pokazuje, że u pacjentów z epilepsją lęk i depresja są częste, ale często nieleczne. Naukowcy rozmawiali z 16 pacjentami i odkryli, że głównymi problemami w dostępie do pomocy są słaba komunikacja z lekarzem, problemy z transportem i obawy przed przyjmowaniem leków. Najważniejszym czynnikiem ułatwiającym leczenie była zaufanie do lekarza, wsparcie rodziny i grup pomocy, a pacjenci byli zadowoleni, gdy neurolog sam pomagał im w leczeniu depresji i lęku.
Oryginalny abstract (angielski)
OBJECTIVES: Anxiety and depression are common in epilepsy and often undertreated, yet little is known about epilepsy patient experiences of mental health care and patient-level barriers and facilitators to mental health care. We aimed to evaluate epilepsy patient perspectives on anxiety and depression and its treatment using qualitative methods, with primary objective to assess barriers and facilitators to care for anxiety and depression. METHODS: Participants recruited from a study examining usual care outcomes among adults with epilepsy and anxiety and/or depression symptoms completed focused semi-structured telephone interviews (NCT03879525). The interview guide explored experiences with anxiety and depression symptoms, treatment preferences, and care barriers and facilitators. Interviews were recorded, professionally transcribed and cleaned to ensure accuracy. Thematic analysis was conducted using deductive and inductive approaches. Two experts in qualitative analysis generated the codebook, coded all interviews and completed analysis using NVIVO software. RESULTS: The study sample (N = 16) included 11 women (69%). Four participants (25%) identified as Black, one as Native American, and one as multiracial; 10 (63%) identified as white/non-Hispanic. Most participants indicated current significant impact of anxiety and/or depression on daily life, and many discussed a link between anxiety and/or depression and their epilepsy, including fear related to Sudden Unexpected Death in Epilepsy (SUDEP). Most participants had previously engaged in treatment for anxiety and/or depression, most often medications, psychotherapy, or healthy living behaviors. Top barriers in seeking treatment for anxiety and/or depression were provider rapport/communication, transportation limitations, and individual hesitancy to seek treatment or add medication. Treatment facilitators included family, support groups, and neurologist efforts to facilitate treatment. Trust emerged as a key theme in provider interactions across various provider specialties, including neurology. CONCLUSION: While barriers and facilitators to mental health care in epilepsy were identified at many levels for potential intervention, ranging from individual patient-level to broader societal/social factors, key actionable contributors at the neurology provider level were identified. Trust and provider rapport/communications were important drivers of mental health treatment experience, neurologists' willingness to serve as mental health provider was a key facilitator, and participants were comfortable with their neurologist acting as mental health provider.